Niels Murawski

2.7k total citations
39 papers, 964 citations indexed

About

Niels Murawski is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Niels Murawski has authored 39 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pathology and Forensic Medicine, 19 papers in Genetics and 18 papers in Oncology. Recurrent topics in Niels Murawski's work include Lymphoma Diagnosis and Treatment (26 papers), Chronic Lymphocytic Leukemia Research (19 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Niels Murawski is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Chronic Lymphocytic Leukemia Research (19 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Niels Murawski collaborates with scholars based in Germany, Switzerland and Italy. Niels Murawski's co-authors include Michael Pfreundschuh, Gerhard Held, Carsten Zwick, Samira Zeynalova, Norbert Schmitz, Viola Poeschel, Tanja Rixecker, Martin H. J. Wiesen, Marcel Reiser and Marita Ziepert and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Niels Murawski

35 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Niels Murawski Germany 16 716 483 340 298 123 39 964
Alice Di Rocco Italy 16 775 1.1× 466 1.0× 317 0.9× 270 0.9× 103 0.8× 64 1.1k
Eve Gallop‐Evans United Kingdom 14 610 0.9× 375 0.8× 266 0.8× 255 0.9× 121 1.0× 27 892
Viola Poeschel Germany 13 707 1.0× 459 1.0× 236 0.7× 269 0.9× 120 1.0× 39 872
Allison Crosby‐Thompson United States 6 675 0.9× 393 0.8× 239 0.7× 181 0.6× 93 0.8× 11 891
Alden A. Moccia Switzerland 15 774 1.1× 475 1.0× 259 0.8× 207 0.7× 117 1.0× 39 871
Alina S. Gerrie Canada 18 800 1.1× 465 1.0× 260 0.8× 422 1.4× 70 0.6× 110 1.1k
Manuel Gotti Italy 13 819 1.1× 374 0.8× 249 0.7× 389 1.3× 131 1.1× 39 1.0k
Maria Giuseppina Cabras Italy 13 605 0.8× 261 0.5× 290 0.9× 184 0.6× 149 1.2× 30 768
Reem Karmali United States 17 647 0.9× 559 1.2× 241 0.7× 192 0.6× 59 0.5× 116 1.0k
Sophie Lefort France 6 994 1.4× 698 1.4× 283 0.8× 352 1.2× 86 0.7× 10 1.3k

Countries citing papers authored by Niels Murawski

Since Specialization
Citations

This map shows the geographic impact of Niels Murawski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niels Murawski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niels Murawski more than expected).

Fields of papers citing papers by Niels Murawski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niels Murawski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niels Murawski. The network helps show where Niels Murawski may publish in the future.

Co-authorship network of co-authors of Niels Murawski

This figure shows the co-authorship network connecting the top 25 collaborators of Niels Murawski. A scholar is included among the top collaborators of Niels Murawski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niels Murawski. Niels Murawski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thurner, Lorenz, Natalie Fadle, Joerg Thomas Bittenbring, et al.. (2021). LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome. Blood. 137(23). 3251–3258. 7 indexed citations
2.
Dlugaiczyk, Julia, et al.. (2021). Ein Fall von M. Menière – oder doch mehr?. HNO. 70(2). 148–150. 1 indexed citations
3.
Roth, Sophie, Fabian K. Berger, Andreas Link, et al.. (2020). Application and clinical impact of the RESIST-4 O.K.N.V. rapid diagnostic test for carbapenemase detection in blood cultures and clinical samples. European Journal of Clinical Microbiology & Infectious Diseases. 40(2). 423–428. 4 indexed citations
4.
Bewarder, Moritz, Gerhard Held, Lorenz Thurner, et al.. (2020). Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential. Cancer Immunology Immunotherapy. 69(8). 1535–1548. 4 indexed citations
5.
Ahlgrimm, Manfred, Lorenz Thurner, Moritz Bewarder, et al.. (2020). Insertion site of central venous catheter correlates with catheter-related infectious events in patients undergoing intensive chemotherapy. Bone Marrow Transplantation. 56(1). 195–201. 7 indexed citations
6.
Pfreundschuh, Michael, Niels Murawski, Marita Ziepert, et al.. (2018). Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.. Journal of Clinical Oncology. 36(15_suppl). 7574–7574. 30 indexed citations
7.
Thurner, Lorenz, Natalie Fadle, Evi Regitz, et al.. (2015). The molecular basis for development of proinflammatory autoantibodies to progranulin. Journal of Autoimmunity. 61. 17–28. 16 indexed citations
8.
Pfreundschuh, Michael, Viola Poeschel, Samira Zeynalova, et al.. (2014). Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. Journal of Clinical Oncology. 32(36). 4127–4133. 59 indexed citations
9.
Murawski, Niels, Michael Pfreundschuh, Samira Zeynalova, et al.. (2014). Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL. Annals of Oncology. 25(9). 1800–1806. 48 indexed citations
10.
Pfreundschuh, Michael, Gerhard Held, Samira Zeynalova, et al.. (2014). Increased rituximab (R) doses and effect on risk of elderly male patients with aggressive CD20+ B-cell lymphomas: Results from the SEXIE-R-CHOP-14 trial of the DSHNHL.. Journal of Clinical Oncology. 32(15_suppl). 8501–8501. 15 indexed citations
11.
12.
Murawski, Niels, Gerhard Held, Marita Ziepert, et al.. (2014). The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas. Blood. 124(5). 720–728. 31 indexed citations
13.
Held, Gerhard, Samira Zeynalova, Niels Murawski, et al.. (2013). Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement. Journal of Clinical Oncology. 31(32). 4115–4122. 68 indexed citations
14.
Murawski, Niels, Gerhard Held, Samira Zeynalova, et al.. (2012). Outcome of elderly DLBCL patients with 6xCHOP-14 and 8 rituximab (R) applications given over an extended period (SMARTE-R-CHOP-14 trial of the DSHNHL).. Journal of Clinical Oncology. 30(15_suppl). 8025–8025. 1 indexed citations
15.
Müller, Carsten, Niels Murawski, Martin H. J. Wiesen, et al.. (2012). The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood. 119(14). 3276–3284. 186 indexed citations
16.
Murawski, Niels, Carsten Zwick, & Michael Pfreundschuh. (2010). Unresolved issues in diffuse large B-cell lymphomas. Expert Review of Anticancer Therapy. 10(3). 387–402. 6 indexed citations
17.
Murawski, Niels & Michael Pfreundschuh. (2010). New drugs for aggressive B-cell and T-cell lymphomas. The Lancet Oncology. 11(11). 1074–1085. 41 indexed citations
18.
Zwick, Carsten, Niels Murawski, & Michael Pfreundschuh. (2010). Rituximab in High-Grade Lymphoma. Seminars in Hematology. 47(2). 148–155. 11 indexed citations
19.
20.
Preuss, Klaus‐Dieter, Michael Pfreundschuh, Manfred Ahlgrimm, et al.. (2009). A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS. International Journal of Cancer. 125(3). 656–661. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Di Rocco Breakdown of academic impact, for papers by Eve Gallop‐Evans Breakdown of academic impact, for papers by Viola Poeschel Breakdown of academic impact, for papers by Allison Crosby‐Thompson Breakdown of academic impact, for papers by Alden A. Moccia Breakdown of academic impact, for papers by Alina S. Gerrie Breakdown of academic impact, for papers by Manuel Gotti Breakdown of academic impact, for papers by Maria Giuseppina Cabras Breakdown of academic impact, for papers by Reem Karmali Breakdown of academic impact, for papers by Sophie Lefort
Rankless by CCL
2026